Mechanism of Action: Bile-acid Binding Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Bile-acid Binding Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 211119-002 | Apr 6, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 211856-001 | Oct 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Tagi | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 209597-001 | Mar 9, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alkem Labs Ltd | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 211856-002 | Oct 19, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Tagi | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 209597-002 | Mar 9, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Endo Operations | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 077204-001 | Aug 26, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Zydus Pharms | CHOLESTYRAMINE | cholestyramine | POWDER;ORAL | 202901-001 | Jul 2, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
